Codex DNA (DNAY) Competitor Comparison
We are evaluating the key criteria listed to compare Codex DNA (DNAY) against its competitors in the Medical Devices industry.
Market Capitalization
81 / 92Gross Profits
76 / 85Total Revenue
0 / 89EBITDA
0 / 90Free Cashflow
0 / 90Quick Ratio
0 / 90Earnings per Share
0 / 90Dividend yield
0 / 8Total Cash
0 / 90Performance 3 years
81 / 92Performance 5 years
80 / 92Performance 10 years
75 / 92Linearity 3 years
76 / 92Linearity 5 years
76 / 92Linearity 10 years
59 / 92Total Rank
17 / 92Dividend Rank
86 / 92Valuation Rank
44 / 92Piotroski Rank
24 / 92Muliplier Rank
19 / 92Total Cash - DNAY ranking 0 / 90
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.